A Phase II/III Study to Assess the Safety and Immunogenicity of subcutaneous DNK-FLU in Healthy Japanese Children

Trial Profile

A Phase II/III Study to Assess the Safety and Immunogenicity of subcutaneous DNK-FLU in Healthy Japanese Children

Completed
Phase of Trial: Phase II/III

Latest Information Update: 01 Jun 2016

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Denka Seiken
  • Most Recent Events

    • 01 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top